Innate Pharma S.A.
Status: Publicly traded
Direct answer
Innate Pharma S.A. is publicly traded on NASDAQ under the ticker IPHA.
Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. The company primarily targets oncology indications across France and internationally, with some programs also addressing inflammatory diseases and viral infections. Its clinical-stage pipeline features several key...
Can you invest in Innate Pharma S.A.?
Yes. Innate Pharma S.A. trades publicly on NASDAQ as IPHA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Innate Pharma S.A.
Detailed equity research is provided by MarketSnap.